RVP NYSE Surgical & Medical Instruments & Apparatus Financials FY2016βFY2025
Retractable Technologies Inc had $38.3M of revenue in fiscal 2025, up 15.8% on the year before. Over five years, revenue changed β14.1% a year on average.
Last close Β· Oct 23, 2026
$0.58
0.3%Hi! I read Retractable Technologies Incβs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+15.8%
Yes. Sales grew 15.8% last year.
Does it make a profit?
β32.8%
No. It lost money last year.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Retractable Technologies Inc did it, and the next one. Share prices often move a lot on those days.
Next results
November 13, 2026
Friday Β· in 18 days
| Date | Results for | Time | Source |
|---|---|---|---|
| Aug 14, 2026 | Q2 '26 | After the market closes | 10-Q β |
| May 15, 2026 | Q1 '26 | During market hours | 10-Q β |
| Mar 27, 2026 | Q4 '25 | During market hours | 10-K β |
| Nov 14, 2025 | Q3 '25 | During market hours | 10-Q β |
| Aug 14, 2025 | Q2 '25 | During market hours | 10-Q β |
| May 15, 2025 | Q1 '25 | During market hours | 10-Q β |
| Mar 28, 2025 | Q4 '24 | During market hours | 10-K β |
| Nov 14, 2024 | Q3 '24 | During market hours | 10-Q β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Retractable Technologies Inc had $38.3M of revenue in fiscal 2025, up 15.8% on the year before. Over five years, revenue changed β14.1% a year on average. Its operating margin was β55.3%, up 8.5Β pts: of every 100 in sales, about β55 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Retractable Technologies Inc lost $12.6M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Retractable Technologies Inc has $1.4M more cash than debt.
Cash, debt and the ratios that show how comfortably Retractable Technologies Inc can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $29.2M | $19.7M | $12.7M | $4.2M | $2.6M |
| Debt incl. finance leases | $2.1M | $1.8M | $1.5M | $1.2M | $1.2M |
| Net debt / EBITDA | β0.4x | β4.8x | β | β | β |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 319.5x | β5.0x | β75.5x | β172.3x | β240.9x |
| Current ratio | 3.0x | 7.3x | 8.3x | 8.3x | 6.6x |
| Quick ratio | 2.4x | 5.6x | 6.4x | 6.2x | 4.8x |
| Total assets | $206M | $196M | $180M | $161M | $143M |
| Total liabilities | $107M | $89.1M | $80.4M | $73.6M | $68.3M |
| Shareholders' equity | $99.2M | $107M | $99.3M | $87.2M | $74.4M |
| Net debt (β = net cash) | β$27.1M | β$17.9M | β$11.1M | β$3.0M | β$1.4M |
KIRA Β· Its return on capital was β23.0%: every 100 invested in the business earned about β23 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Retractable Technologies Inc passes 5 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 9 | 4 / 9 | 7 / 9 | 5 / 9 | 7 / 9 | 6 / 9 | 5 / 9 | 4 / 9 | 5 / 9 |
| Accruals ratio | β7.5% | β2.1% | β0.4% | 2.5% | 7.3% | 15.0% | β5.8% | β5.2% | β0.2% | β3.6% |
| Altman Z'' | 2.77 | 2.10 | 1.92 | 3.88 | 4.79 | 6.19 | 4.56 | 4.06 | 3.54 | 2.92 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $29.8M | $34.5M | $33.3M | $41.8M | $81.9M | $188M | $94.8M | $43.6M | $33.0M | $38.3M |
| Gross profit | $10.3M | $10.0M | $10.2M | $14.1M | $37.0M | $95.4M | $28.3M | $9.1M | β$1.0M | $0.0M |
| Research and development | $0.6M | $0.7M | $0.6M | $0.5M | $0.6M | $0.9M | $0.5M | $0.6M | $0.7M | $0.7M |
| Operating income | β$3.5M | β$3.8M | β$1.3M | $3.0M | $24.1M | $72.6M | β$0.9M | β$11.5M | β$21.1M | β$21.2M |
| Interest expense | $0.2M | $0.2M | $0.2M | $0.2M | $0.3M | $0.2M | $0.2M | $0.2M | $0.1M | $0.1M |
| Pretax income | β$3.7M | β$3.9M | β$1.4M | $3.2M | $26.1M | $75.0M | $5.2M | β$8.9M | β$3.5M | β$12.3M |
| Income tax | $0.0M | β$0.2M | β$0.0M | $0.0M | $1.9M | $18.9M | $0.1M | β$1.9M | $8.4M | $0.3M |
| Net income | β$3.7M | β$3.7M | β$1.3M | $3.1M | $24.2M | $56.1M | $5.1M | β$7.0M | β$11.9M | β$12.6M |
| Net income to common | β$4.4M | β$4.4M | β$2.0M | $2.4M | $26.6M | $55.8M | $4.8M | β$7.2M | β$12.1M | β$12.8M |
| Diluted EPS | β$0.15 | β$0.14 | β$0.06 | $0.07 | $0.80 | $1.63 | $0.15 | β$0.24 | β$0.40 | β$0.43 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | β$0.8M | β$2.9M | β$1.2M | $2.2M | $19.0M | $32.8M | $16.8M | $2.8M | β$11.6M | β$7.1M |
| Capital expenditure | $1.9M | $0.1M | $0.4M | $0.6M | $21.0M | $58.4M | $16.8M | $0.9M | $1.4M | β |
| Free cash flow | β$2.7M | β$3.0M | β$1.6M | $1.6M | β$2.1M | β$25.6M | β$0.1M | $1.9M | β$13.0M | β |
| Depreciation and amortization | $0.9M | $0.8M | $0.9M | $0.9M | $0.8M | $1.3M | $4.6M | $7.5M | $7.6M | $7.8M |
| Stock-based compensation | $0.4M | $0.7M | $0.0M | $0.0M | $0.0M | $3.7M | $10.1M | $0.0M | $0.0M | β |
| Share buybacks | β | β | β | β | β | $5.3M | $7.6M | β | β | β |
| Dividends and buybacks | β | β | β | β | β | $5.3M | $7.6M | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $16.2M | $14.9M | $9.6M | $5.9M | $17.6M | $29.2M | $19.7M | $12.7M | $4.2M | $2.6M |
| Total debt | $3.9M | $3.5M | $3.0M | $2.6M | $3.7M | $2.1M | $1.8M | $1.5M | $1.2M | $0.9M |
| Finance lease liabilities | β | β | β | β | β | β | β | β | β | $0.3M |
| Current assets | $26.7M | $26.6M | $25.8M | $28.4M | $69.5M | $105M | $88.8M | $77.6M | $73.3M | $63.1M |
| Current liabilities | $7.2M | $7.9M | $8.6M | $8.3M | $27.9M | $35.3M | $12.1M | $9.4M | $8.8M | $9.6M |
| Inventory | $7.0M | $6.2M | $7.5M | $7.5M | $10.2M | $20.6M | $20.7M | $17.6M | $19.2M | $17.2M |
| Property and equipment, net | $12.1M | $11.4M | $10.9M | $10.6M | $30.8M | $87.9M | $100M | $93.5M | $87.3M | $79.2M |
| Total assets | $38.8M | $38.2M | $37.0M | $39.2M | $105M | $206M | $196M | $180M | $161M | $143M |
| Total liabilities | $10.7M | $11.0M | $11.3M | $10.6M | $55.1M | $107M | $89.1M | $80.4M | $73.6M | $68.3M |
| Shareholders' equity | $28.1M | $27.2M | $25.6M | $28.5M | $49.9M | $99.2M | $107M | $99.3M | $87.2M | $74.4M |
| Margins | ||||||||||
| Gross margin | 34.7% | 28.9% | 30.7% | 33.8% | 45.2% | 50.6% | 29.8% | 20.9% | β3.1% | 0.1% |
| Operating margin | β11.8% | β11.0% | β4.0% | 7.1% | 29.4% | 38.5% | β0.9% | β26.4% | β63.9% | β55.3% |
| EBITDA margin | β8.8% | β8.5% | β1.3% | 9.1% | 30.4% | 39.2% | 4.0% | β9.1% | β41.0% | β35.0% |
| Net margin | β12.4% | β10.8% | β4.0% | 7.5% | 29.6% | 29.8% | 5.4% | β16.1% | β36.0% | β32.8% |
| FCF margin | β9.2% | β8.7% | β4.7% | 3.7% | β2.5% | β13.6% | β0.1% | 4.4% | β39.3% | β |
| Returns | ||||||||||
| Return on capital | β17.5% | β18.9% | β5.5% | 11.7% | 62.0% | 75.3% | β0.9% | β10.3% | β19.8% | β23.0% |
| Return on capital employed | β11.1% | β12.5% | β4.7% | 9.6% | 31.2% | 42.5% | β0.5% | β6.7% | β13.9% | β15.9% |
| Return on equity | β13.1% | β13.5% | β5.1% | 11.6% | 61.8% | 75.2% | 4.9% | β6.8% | β12.7% | β15.6% |
| Return on assets | β9.5% | β9.7% | β3.6% | 8.3% | 33.6% | 36.0% | 2.5% | β3.7% | β7.0% | β8.3% |
| Return on tangible equity | β15.7% | β16.3% | β8.0% | 8.6% | 53.4% | 56.3% | 4.5% | β7.3% | β13.9% | β17.2% |
| Growth | ||||||||||
| Revenue growth | β | 15.6% | β3.5% | 25.6% | 95.9% | 130.1% | β49.7% | β54.0% | β24.2% | 15.8% |
| Net income growth | β | β | β | β | 669.4% | 131.5% | β90.9% | β238.0% | β | β |
| EPS growth | β | β | β | β | 1,042.9% | 103.8% | β90.8% | β260.0% | β | β |
| FCF growth | β | β | β | β | β231.4% | β | β | β | β779.1% | β |
| Share count change | β | 8.9% | 2.2% | 0.0% | 1.9% | 2.8% | β3.7% | β9.2% | 0.0% | 0.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β0.9x | β0.6x | β0.4x | β4.8x | β | β | β |
| Debt / equity | 0.1x | 0.1x | 0.1x | 0.1x | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | β16.4x | β17.9x | β7.5x | 17.8x | 92.5x | 319.5x | β5.0x | β75.5x | β172.3x | β240.9x |
| Current ratio | 3.7x | 3.4x | 3.0x | 3.4x | 2.5x | 3.0x | 7.3x | 8.3x | 8.3x | 6.6x |
| Quick ratio | 2.7x | 2.6x | 2.1x | 2.5x | 2.1x | 2.4x | 5.6x | 6.4x | 6.2x | 4.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 6.5% | 0.3% | 1.1% | 1.5% | 25.7% | 31.0% | 17.7% | 2.0% | 4.4% | β |
| Stock comp / revenue | 1.3% | 1.9% | 0.0% | 0.0% | 0.0% | 1.9% | 10.7% | 0.0% | 0.0% | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 4.0 | 7.0 | 5.0 | 7.0 | 6.0 | 5.0 | 4.0 | 5.0 |
| Altman Z'' | 2.8 | 2.1 | 1.9 | 3.9 | 4.8 | 6.2 | 4.6 | 4.1 | 3.5 | 2.9 |
| Accruals ratio | β7.5% | β2.1% | β0.4% | 2.5% | 7.3% | 15.0% | β5.8% | β5.2% | β0.2% | β3.6% |
Source: SEC EDGAR XBRL filings (CIK 0000946563). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
